Questions remain as to how FDA inspection differences between domestic and foreign drug facilities will play out.

Antares Therapeutics has secured $177m in Series A financing round for the development of precision medicines.

SEED Therapeutics Inc. has announced the appointment of Dr. Bill Desmarais, Ph.D., MBA, as Chief Financial Officer and Chief ...